STONKWHISPER
← Back to Intel
Insider ActivityARTV

Aslan Fred, Chief Executive Officer at Artiva Biotherapeutics, Inc., sold $244K of ARTV

Updated Jun 21, 2026
Aslan Fred Chief Executive Officer
Artiva Biotherapeutics, Inc. · $ARTV
$244K Total Value
27,116 Shares Traded
$9.0077 Price / Share
1,535,082 Shares Owned After
2026-05-19 Filing Date

Transaction Details

InsiderAslan Fred
TitleChief Executive Officer
CompanyArtiva Biotherapeutics, Inc.
TickerARTV
Transaction TypeSale
Transaction Date2026-05-19
Shares Traded27,116
Price Per Share$9.0077
Total Value$244K
Filed Date2026-05-19
Accession Number0001193125-26-231506

Ownership Context

Shares Owned After Transaction1,535,082
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-231506

Other Insider Trades — ARTV

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ARTV — Artiva Biotherapeutics, Inc. →

Track ARTV insider activity in real time on The Wire →

Get alerts when Aslan Fred files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:11 UTC

Want real-time data? Access The Wire for live sentiment tracking.